Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Journal of Translational Medicine Year : 2012

Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists

Fichier principal
Vignette du fichier
1479-5876-10-S3-O2.pdf (119.96 Ko) Télécharger le fichier
1479-5876-10-S3-O2.xml (4.64 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Dates and versions

inserm-00758217 , version 1 (28-11-2012)

Identifiers

  • HAL Id : inserm-00758217 , version 1

Cite

Nicolas Poirier, Nahzli Dilek, Caroline Mary, Bernard Vanhove. Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists. 7th European Workshop on Immune-Mediated Inflammatory Diseases, Nov 2012, Netherlands. pp.O2. ⟨inserm-00758217⟩
52 View
114 Download

Share

Gmail Facebook X LinkedIn More